To Explore the Safety and Efficacy of Intravenous Infusion of Different Doses of Lidocaine in Patients
Status:
Recruiting
Trial end date:
2022-09-27
Target enrollment:
Participant gender:
Summary
All patients who met the inclusion criteria were randomly divided into four groups, 30 cases
in each group, which were lidocaine group 1, lidocaine group 1.5, lidocaine group 2, and the
placebo group In lidocaine group 1, lidocaine group 1.5, and lidocaine group 2, 1% lidocaine
1.5 mg/kg was intravenously infused with a micropump after anesthesia induction, and the
infusion was completed within 10 minutes according to the ideal body weight, and then
continued for 1% lidocaine was infused at 1 mg/kg.h, 1.5 mg/kg.h and 2 mg/kg.h respectively
until the end of the operation. In the placebo group, the same volume of normal saline was
used instead.